Robert Rosen, President at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 400,000 shares at $22.50 ($9.3M) on 2016-04-19, disclosed to the SEC on 2016-04-21.
Open-market sale of $9.3M HRTX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 60,925 | $1.4M | 14.7% |
| 2 | $22.50 | 60,925 | $1.4M | 14.8% |
| 3 | $23.47 | 76,949 | $1.8M | 19.4% |
| 4 | $23.47 | 76,949 | $1.8M | 19.4% |
| 5 | $24.49 | 32,224 | $789K | 8.5% |
| 6 | $24.49 | 32,224 |
| $789K |
| 8.5% |
| 7 | $25.11 | 6,230 | $156K | 1.7% |
| 8 | $25.11 | 6,230 | $156K | 1.7% |
| 9 | $22.19 | 4,010 | $89K | 1.0% |
| 10 | $22.19 | 4,010 | $89K | 1.0% |
| 11 | $22.15 | 19,662 | $435K | 4.7% |
| 12 | $22.15 | 19,662 | $436K | 4.7% |
| Total | $23.23 avg | 400,000 | $9.3M | 100% |
| Filing → |